BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 34680290)

  • 1. Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents.
    Tadmor T; Levy I
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Richter transformation of CLL.
    Jain N; Keating MJ
    Expert Rev Hematol; 2016 Aug; 9(8):793-801. PubMed ID: 27351634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
    Jamroziak K; Tadmor T; Robak T; Polliack A
    Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.
    Favini C; Talotta D; Almasri M; Andorno A; Rasi S; Adhinaveni R; Kogila S; Awikeh B; Schipani M; Boggione P; Mouhssine S; Ghanej J; Al Essa W; Mahmoud AM; Dondolin R; Alessa N; Margiotta Casaluci G; Boldorini R; Gattei V; Gaidano G; Moia R
    Br J Haematol; 2022 Sep; 198(6):1016-1022. PubMed ID: 35829664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clonality relatedness and molecular characteristics of Richter transformation].
    Sha YQ; Jiang R; Miao Y; Qiu TL; Qin SC; Qiu JY; Mi HL; Wu W; Qiao C; Wu YJ; Xia Y; Wang L; Fan L; Xu W; Li JY; Zhu HY
    Zhonghua Xue Ye Xue Za Zhi; 2022 Oct; 43(10):841-847. PubMed ID: 36709198
    [No Abstract]   [Full Text] [Related]  

  • 6. Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of Novel Agents.
    Levy Yurkovski I; Tadmor T
    Acta Haematol; 2024; 147(1):73-83. PubMed ID: 37666234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting Richter transformation in the era of novel CLL agents.
    Petrackova A; Turcsanyi P; Papajik T; Kriegova E
    Blood Rev; 2021 Sep; 49():100824. PubMed ID: 33775465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Approach to Diagnosis of Richter Transformation in Chronic Lymphocytic Leukemia.
    Broadway-Duren J
    J Adv Pract Oncol; 2022 Jul; 13(5):535-538. PubMed ID: 35910501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Richter transformation of chronic lymphocytic leukemia in the era of novel agents.
    Wang Y; Ding W
    Clin Adv Hematol Oncol; 2020 Jun; 18(6):348-357. PubMed ID: 32649656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemotherapy for Richter syndrome: current insights.
    Puła B; Salomon-Perzyński A; Prochorec-Sobieszek M; Jamroziak K
    Immunotargets Ther; 2019; 8():1-14. PubMed ID: 30788335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
    He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
    Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group.
    Tadmor T; Shvidel L; Goldschmidt N; Ruchlemer R; Fineman R; Bairey O; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A
    Anticancer Res; 2014 Feb; 34(2):785-90. PubMed ID: 24511013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Richter Transformation of Chronic Lymphocytic Leukemia in the Modern Era.
    Briski R; Taylor J
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade B-Cell lymphoma with
    Rogers TS; Gardner JA; Devitt KA
    Autops Case Rep; 2019; 9(3):e2019090. PubMed ID: 31440479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenomic features of Richter transformation.
    Woroniecka R; Rymkiewicz G; Bystydzienski Z; Pienkowska-Grela B; Rygier J; Malawska N; Wojtkowska K; Goral N; Blachnio K; Chmielewski M; Bartnik-Glaska M; Grygalewicz B
    Mol Cytogenet; 2023 Nov; 16(1):31. PubMed ID: 37941034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.
    Khan M; Siddiqi R; Thompson PA
    Ann Hematol; 2018 Jan; 97(1):1-15. PubMed ID: 29063177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Richter syndrome.
    Rossi D; Gaidano G
    Adv Exp Med Biol; 2013; 792():173-91. PubMed ID: 24014297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How we treat Richter syndrome.
    Parikh SA; Kay NE; Shanafelt TD
    Blood; 2014 Mar; 123(11):1647-57. PubMed ID: 24421328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia.
    Innocenti I; Rossi D; Trapè G; Autore F; Larocca LM; Gomes V; Cerri M; Falcucci P; Sica S; Gaidano G; Laurenti L
    Hematol Oncol; 2018 Feb; ():. PubMed ID: 29484684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.